Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Clinical implication of KRAS mutation variants in patients with resected colon cancer.
Authors
Jin Ho Baek
Department of Hematology and Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea
Jin Ho Baek , Byung Woog Kang , Gyu Seog Choi , Jong Gwang Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.179
Abstract #
179
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Prognostic value of KRAS exon 2 gene mutations in stage III colon cancer: Post hoc analyses of the PETACC8 trial.
First Author: Julien Taïeb
Poster
2017 ASCO Annual Meeting
Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance).
First Author: Temidayo Fadelu
Poster
2013 ASCO Annual Meeting
Subgroup analyses results of the PETACC8 phase III trial comparing adjuvant FOLFOX4 with or without cetuximab (CTX) in resected stage III colon cancer (CC).
First Author: Julien Taïeb
Poster
2021 ASCO Annual Meeting
Association of plasma adiponectin with tumor infiltrating lymphocytes and survival in patients with stage III colon cancer (NCCTG N0147; Alliance).
First Author: Frank A. Sinicrope